TS CR 2 B co / IgG / Life Technologies / dPaul F. Glenn Laboratories / Myc shRNA1 2 3 Day co / Millipore / Takara / Agilent / GlaxoSmithKline / COX / Wiman KG / D.A.S. / /
Currency
pence / / /
Event
Product Issues / /
Facility
Massachusetts General Hospital / Howard Hughes Medical Institute / Ambion Silencer Select Human Genome siRNA Library / Harvard Medical School Institute / Institute of Chemistry / Women’s Hospital / ORFeome library / eJoslin Diabetes Center / bHoward Hughes Medical Institute / /
glioma tumor / different ORF / putative tumor / Mitochondrial disorders / ORF / human tumors / primary mitochondrial disorders / gliomas / median ORF / pooled ORF / human diseases / Mitochondrial diseases / age-related diseases / MS / colorectal and esophageal cancers / tumor / mitochondrial dysfunction / chemically induced skin cancers / cancer / disease / each ORF / glioblastoma cell lines / 19q-arm glioma tumor / individual ORF / metabolic syndrome / mitochondrial myopathy / infection / potential tumor / human disease / respiratory chain disorders / /
MedicalTreatment
radiation / /
NaturalFeature
MT DR / FITC channel / Ryan MT / MT DR FACS / /
Organization
Harvard Medical School / TS CR / United Mitochondrial Disease Foundation / DC CP / Women’s Hospital / Massachusetts General Hospital / Department of Genetics / bHoward Hughes Medical Institute / CR GP / Division of Genetics / Brigham and Women / Paul F. Glenn Foundation / US Federal Reserve / Institute of Chemistry and Cell Biology / eJoslin Diabetes Center / Howard Hughes Medical Institute / Juvenile Diabetes Foundation / Harvard Medical School Institute for Chemistry and Chemical Biology / /
Person
Stephen J. Elledgea / Stain / Abigail N. Boducha / Ai / David A. Sinclaira / Alvin J. Y. Linga / John C. Yoona / Stephen J. Elledge / Michael J. Steinbaugha / Laura M. Sacka / Dong-Young Donna Leea / Yoon et al. Myc / T. Keith Blackwella / /